A new computer model screens drugs for unintended cardiac side effects, especially arrhythmia risk, report researchers. “One main reason for a drug being removed from the market is potentially life-threatening arrhythmias,” says study co-leader Colleen E. Clancy, professor of physiology and membrane biology at the University of California, Davis. “Even drugs developed to treat arrhythmia...